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Background. The influence of type 2 diabetes mellitus (DM2) on systolic function is par-
tially determined by the coronary vasodilator function, nevertheless, an independent effect is
suspected. We evaluated the relationship between DM2 and systolic function considering PET
quantitative myocardial perfusion.
Methods. We analyzed 585 patients without a previous myocardial infarction referred to a
rest and adenosine stress Nitrogen-13 ammonia PET. A bootstrapped multiple linear regression
analysis was performed using DM2, stress myocardial blood flow (sMBF), myocardial perfusion
reserve (MPR), and clinical risk factors as predictors and LVEF as the outcome variable; an
interaction term was additionally investigated.
Results. Two hundred and ninety male and 295 female patients (mean age 65.3 ± 9.9 and
67.4 ± 10 years, respectively) were included. 57.1% presented hypertension, 16% smoking,
37.6% hypercholesterolemia, 33.8% family history for CAD, and 15.2% DM2. The mean MPR
was 2.13 ± 0.48 and 2.21 ± 0.60, mean sMBF was 2.01 ± 0.51 and 2.15 ± 0.54, and mean LVEF
was 63% ± 10.4 and 67% ± 10.1 for diabetics and non-diabetics, respectively. A significant
relation was detected for sMBF (B 5 5.830 95% CI [3.505, 9.549], P 5 .001) and DM2
(B 5 22.599 95% CI [25.125, 20.119], P 5 .03) with LVEF. The interaction (DM2 3 sMBF)
yielded no significance (P 5 .512).
Conclusion. DM2 influences PET-measured systolic function in patients without previous
myocardial infarction independently from myocardial perfusion parameters. Our study sup-
ports the importance of DM2 as an independent risk factor for deteriorating systolic function.
(J Nucl Cardiol 2017;24:1305–11.)
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DM2 Type 2 diabetes mellitus
PET Positron emission tomography
PET/CT Positron emission tomography/com-
puted tomography
CAD Coronary artery disease
LVEF Left ventricular ejection fraction
MI Myocardial infarction
sMBF Stress myocardial blood flow
rMBF Rest myocardial blood flow
MPR Myocardial perfusion reserve
RPP Rate pressure product
See related editorial, pp. 1312–1313
INTRODUCTION
The importance of type 2 diabetes mellitus (DM2)
in cardiovascular disease, ranging from endothelial
dysfunction1 to heart failure, has been of great interest
for clinicians. During the last 50 years, the cardiac
disease profile has substantially shifted from a high
acute mortality in the setting of myocardial infarction
(MI) to a substantial decrease in first-event mortality and
an increasing number of patients with progressive
ventricular dysfunction and end-stage cardiac disease.
Therefore, there is an interest in the independent
influence of DM2 in coronary artery disease (CAD)-
related outcomes. So far, the influence of DM2 on
ventricular function is suggested to be mediated by the
hampering of coronary vasculature dilatory function and
microvascular involvement with further death risk
modification dependent on its magnitude.2 However, a
direct influence in the myocardium has also been
proposed to underlie the diabetic cardiomyopathy phe-
notype.3–7 PET quantitative myocardial perfusion
scanning constitutes a state-of-the-art technique for the
evaluation of myocardial blood flow during rest (rMBF)
and stress (sMBF) and for the determination of the
myocardial perfusion reserve (MPR). Moreover, gated
PET represents a validated technique for systolic func-
tion assessment through the left ventricle ejection
fraction (LVEF).8 The present study aimed to evaluate
whether there is a relationship between DM2 and
systolic function when accounting for absolute quanti-
tative perfusion (sMBF and MPR) and traditional




We retrospectively analyzed a prospectively constructed
database with data from 2012 to 2014. From the patients
referred for PET myocardial perfusion scanning for evaluation
of known or suspected CAD, we selected patients without a
previous myocardial infarction as registered in the patients’
clinical history and confirmed with the absence of fixed
perfusion defects in the scan results. In total, 585 patients were
included for the analysis and demographic data regarding
gender, age, body mass index, and cardiovascular risk factors
including hypertension, hypercholesterolemia, smoking status,
and DM2 were extracted from the electronic file system. DM2
was operationalized as a dichotomous variable for the presence
or absence of the disease.
PET Acquisition
Every patient underwent a two-phase (rest and adenosine
stress) PET scan with the use of Nitrogen-13 ammonia as the
perfusion radiotracer. All image data were acquired in list
mode on a Siemens Biograph-16 TruePoint PET/CT (Siemens
Healthcare, Knoxville, USA) with the TrueV option (the axial
field of view of 21.6 cm). This 3D system consists of a 16-slice
CT and a PET scanner with four rings of lutetium oxyorthosil-
icate (LSO) detectors. Patients were instructed to fast
overnight and to avoid the consumption of methylxantine-,
caffeine-containing beverages or medications for 24 hours
before the study. Previous to the rest perfusion phase of the
scans, a CT-based transmission scan (130 kVp; 25 ref.mAs;
helical scan mode with a pitch of 0.95) was obtained during
normal breathing for correction of photon attenuation for all
PET acquisitions. The automatic co-registration of the CT
attenuation map with the PET images was verified visually and
alignment was corrected when necessary by an experienced
nuclear medicine technician. During rest, myocardial perfusion
was assessed using 300 MBq of Nitrogen-13 ammonia. Imag-
ing lasted for 12 minutes and began simultaneously with
peripheral injection of the radiotracer. The Nitrogen-13
ammonia was administered as a single intravenous bolus (8-
10 s with infusion rate 0.4 mL/second) followed by a 10 mL
saline flush. Pharmacologic stress imaging was performed one
minute later and beginning with a 6-minutes adenosine
infusion through a peripheral vein (140 lg/kg/minute). A
second dose of 400 MBq Nitrogen-13 ammonia was injected
in the fourth minute of the adenosine administration and image
acquisition was started, in the same way, simultaneously with
the radiotracer bolus. Static, dynamic, and 16-bin ECG-gated
images were generated from the list mode data. Patient
emission data was reconstructed using 3D attenuation-
weighted ordered subsets expectation maximization
(OSEM3D) reconstruction with 168 9 168 matrix, zoom 2,
Gaussian filter with a full width at half maximum of 5 mm, 2
iterations, and 21 subsets for gated and dynamic images and
TrueX (OSEM3D with PSF) reconstruction with 256 9 256
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matrix, zoom 2, Gaussian filter of 4 mm, 4 iterations, and 8
subsets for static images. CT-based attenuation, scatter, decay,
and random corrections were applied to the reconstructed
images. Dynamic images were reconstructed with 25 frames
for rest: 1 9 10, 12 9 5, 2 9 10, 7 9 30, 2 9 60, and
1 9 180 seconds, and 26 frames for stress: delay 90, 1 9 30,
1 9 10, 12 9 5, 2 9 10, 7 9 30, 2 9 60, and
1 9 180 seconds.
Quantitative Perfusion
Based on the dynamic subsets, left ventricular contours
were assigned automatically using the SyngoMBF software
(Siemens Medical Solutions, Berlin, Germany) with minimum
observer intervention when appropriate. With a previously
described 2-compartment kinetic model for Nitrogen-13
ammonia, stress and rest flow values in mL/g/minute were
computed for each sample on the polar map through the
resulting time-activity curves for global quantification.9
Myocardial perfusion reserve (MPR) was calculated as the
ratio between the MBF during stress (sMBF) and MBF during
rest (rMBF) and therefore expressed adimensionally. rMBF
was corrected for the rate pressure product (RPP) as previously
described. The total MPR and sMBF were calculated within
the whole left ventricular region as parameters of interest for
our analysis.
Left Ventricular Systolic Function
The list mode data were reconstructed in 16-bin ECG-
gated images. The end-systolic and end-diastolic volumes were
determined using Quantitative Gated SPECT 2012 (QGS)
software (Cedars Sinai Medical Center). LVEF was expressed
as the percentage of the end-diastolic volume ejected during
systole.
Statistical Analysis
Continuous variables were explored for sampling distri-
bution through histograms and described as mean ± standard
deviation. Dichotomous variables are described as the number
of occurrences with their associated valid percentage graph-
ically. The univariate analysis was performed through biserial
correlations considering clinical variables, and a difference in
means was explored through an independent samples t test.
Further, a multiple linear regression analysis was performed by
entering gender, age, hypercholesterolemia, hypertension,
smoking habit, DM2, sMBF, and MPR as predictor (indepen-
dent) variables and LVEF as outcome (dependent) variable.
The model was bootstrapped based on 1000 samples with bias-
corrected and accelerated 95% confidence intervals (95% BCa
CIs) for robustness of B coefficients and significance estima-
tors. A second step for the model was performed for testing a
possible interaction between DM2 and both sMBF and MPR. P
values less than .05 were considered significant. All statistical
analyses were performed using SPSS (Released 2013. IBM




A total of 585 consecutive patients, 290 male and 295
female, with a mean age of 65.3 ± 9.9 and 67.4 ±
10.0 years were included in our analysis, respectively.
There was a high prevalence of arterial hypertension
while the rate of patients who were smokers or had
diagnosed DM2 was comparable. Baseline demographic
and perfusion variables are depicted in Table 1.
Quantitative Perfusion Assessment and
Systolic Function
The population had a mean global rMBF of 1.00 ±
0.25 mL/g/minute and a sMBF of 2.11 ± 0.54 mL/g/
minute. Consequently, the calculated ratio expressing
global MPR was 2.18 ± 0.57. Mean LVEF was
65.7 ± 12.2% (Figure 1). The univariate analysis docu-
mented a significant biserial correlation between LVEF
and DM2 (rb = -0.14, P = .03) but not for smoking
(rb = -0.11, P = ns), dyslipidemia (rb = -0.08,
P = ns), or hypertension (rb = 0.005, P = ns). The
bootstrapped correlation between sMBF and LVEF was
found to be significant (r = 0.330 [0.249, 0.420],
P\ .001). We evaluated the difference in mean LVEF
between the patients with and without DM2 finding a
statistically significant lower LVEF in the DM2 group
t = -2.104 SE 1.269, P = .037, d = 0.25 (also
depicted in Figure 1).
Multiple Linear Regression
The bootstrapped multiple linear regression analysis
determined a statistically significant relationship for
gender (P = .001), sMBF (P = .001), and the presence
of DM2 (P = .034) with LVEF. The statistical values
for age (P = .218), dyslipidemia (P = .086), hyperten-
sion (P = .820), and smoking (P = .152) were not
significant. The overall model was assessed through the
change in coefficient of determination, R2 = 0.162,
P\ .001. The corresponding coefficients and BCa 95%
CIs are shown in Table 2. In the second step of the
model, there was no significant interaction between
DM2 and MPR (P = .19) or between DM2 and sMBF
(P = .51), and there was no significant improvement of
the model according to the change R2.
DISCUSSION
We have documented significant relations between
cardiovascular risk factors, quantitative perfusion vari-
ables, and left ventricular systolic function in a large
Journal of Nuclear Cardiology Jua´rez-Orozco et al 1307
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sample of patients referred to non-invasive evaluation in
a specialized imaging center for suspected CAD. Our
results evidenced a statistically significant relationship
between the presence of DM2 and a decrease in LVEF
independent of absolute quantitative perfusion variables
(MPR and sMBF) and additional relevant risk factors
(smoking habit, hypertension, and dyslipidemia).
When considering our population of patients with-
out a previous myocardial infarction, these results line
up with the current view of diabetic cardiomyopathy,6
which conveys a possible direct mechanistic relation
between the pathophysiological state of diabetic patients
and their corresponding left ventricular systolic
function.7
Diabetic cardiomyopathy is defined as ‘‘a distinct
entity characterized by the presence of abnormal
myocardial performance or structure in the absence of
epicardial coronary artery disease, hypertension, and
significant valvular disease.’’4,5 A multitude of direct
pathophysiological mechanisms, such as direct effects of
hyperglycemia, lipotoxicity, advanced glycation end-
products (AGEs) deposition, microvascular refraction,
insulin resistance, and hyperinsulinemia have been
proposed to contribute to the condition, although the
exact pathogenesis is still to be elucidated.7 Diabetic
cardiomyopathy has been proposed to arise from the
additive effect of processes like myocardial interstitial
deposition of AGEs, cardiomyocyte apoptosis, and
reactive interstitial fibrosis with a deleterious effect
that, in parallel with the (micro)vascular affection,
disturb systolic, and diastolic function.6 Therefore, the
main described mechanism of deterioration of the left
ventricular function may not be the hampering of
coronary vasculature dilatory function (linked to
ischemic findings and/or microvascular dysfunction)
alone.2
Previous research has reported a difference in
systolic function measured through LVEF between
patients with and without DM2 in the of setting patients
without CAD.6 Although we found a similar difference
in LVEF between the two groups, the effect size
calculation showed that, in the univariate analysis, this
corresponds to a rather small effect. As such, we
incorporated the variable into a statistical model to
generate a comprehensive overview of its importance in
relation to systolic function (evaluated through LVEF)
in relation to other important factors including: quanti-
tative perfusion parameters sMBF and MPR, both of
which consider hampered myocardial perfusion at all
levels of the coronary vasculature ranging from epicar-
dial significant or non-significant stenoses down to
microvascular or endothelial dysfunction, and other
conventional cardiovascular risk factors (age, gender,
smoking status, hypercholesterolemia, arterial hyperten-
sion, or significant family history for CAD).
Figure 1. Quantitative perfusion and systolic function. The
bar chart shows the mean value for quantitative perfusion
results (MPR, myocardial perfusion reserve; MBF, myocardial
blood flow) and systolic function (LVEF, left ventricle ejection
fraction) in patients with (orange) and without DM2 (blue).
The error bars represent 95% CIs.
Table 1. Baseline population characteristics
Variable Diabetics (n 5 83) Non-diabetics (n 5 459) P value
Men/women (n) 34/49 228/230 .153
Arterial hypertension 74% 55% .010
Smokers 17% 16% .870
Dyslipidemia 42% 37% .325
Family history of CVD 31% 34% .617
Rest MBF (mL/g/minute) 0.98 ± 0.22 1.00 ± 0.26 .244
Stress MBF (mL/g/minute) 2.01 ± 0.51 2.15 ± 0.54 .072
MPR 2.13 ± 0.48 2.21 ± 0.60 .172
CVD, cardiovascular disease; MBF, myocardial blood flow; MPR, myocardial perfusion reserve
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Interestingly, although there was a trend towards
significance for the presence of dyslipidemia in the
analysis, none of the otherwise generally considered
cardiovascular risk factors yielded significance in our
study. We consider that this supports the notion that the
effect of DM2 may be of greater importance regarding
systolic function assessment. A complementary explana-
tion may be that other risk factors, such as age,
dyslipidemia, arterial hypertension, and smoking proba-
bly hamper systolic function through their pathological
effect on coronary vasodilatory function (endothelial
dysfunction leading to coronary [micro]vascular ‘‘stiff-
ness’’), which again was accounted for in our analysis
through the included perfusion variables (sMBF and
MPR). The lack of significance for the interaction term
(DM2 and sMBF) suggested that the significant effect
found for DM2 was not explained by mediation through
myocardial perfusion. Other effects such as cardiac
sympathetic innervation dysfunction10 may play an eti-
ologic role and further research in this area is warranted.
As evidenced by the multiple regression analysis,
DM2 showed a relative greater influence over LVEF
than MPR, but more discrete than gender or sMBF
according to the adjusted B coefficients, as shown in
Table 2. This may suggest that DM2 treatment should
constitute a primordial target for preservation of LVEF,
as much as perfusion optimization.
Recent evidence has demonstrated that the rate of
cardiac death in diabetic patients without known CAD
was low in the presence of a preserved MPR2 and that
this might partially explain the inconsistent relationship
between diabetes mellitus and cardiac risk. We consider
that our explored independent relationship between
DM2 and systolic function may also play a role in it.
The variable gender yielded significance in this
analysis. This was expected when considering previous
evidence of male-female differences in LVEF due to
intrinsic anatomic and physiologic differences linked to
the calculation of ejection fraction.11
Previous studies have repeatedly proven the rela-
tionship between PET-derived perfusion and ventricular
function.12–14 Our study additionally showed a relative
greater importance of sMBF (B = 7.133 [4.550, 9.604],
P = .001) when compared to MPR (by inclusion in the
same regression model). This finding is in line with
recent reports proposing sMBF (hyperemic MBF) as a
better measure of perfusion in patients with suspected
CAD.15–17
Our results add to the body of evidence suggesting a
decrease in systolic function in relation to the presence
of DM2. Additionally, they describe proof of its statis-
tically assessed independent influence when compared
to other risk factors.
NEW KNOWLEDGE GAINED
This study demonstrated a relation between type 2
diabetes mellitus and systolic function in patients
without previous myocardial infarction independently
from and not mediated by quantitative perfusion results.
Additionally, to the previously reported relationship
between PET-derived perfusion and ventricular













LVEF§ Intercept 47.857 39.418 56.920 0.402 .001
Gender 4.380 2.363 6.360 .001*
Age 0.060 -0.039 0.155 .218
Dyslipidemia 1.640 -0.167 3.443 .086
Smoking -1.725 -4.199 .810 .152
Arterial hypertension -0.192 -2.070 1.701 .820
DM2 -2.599 -5.125 -.119 .034*
sMBF 5.830 3.505 9.549 .001*
MPR -0.003 -3.870 .210 .965
Second step (model 1 ? interaction)
Interaction DM2 9 sMBF 1.671 -3.774 7.630 .512
BCa, bias-corrected accelerated; DM2, type 2 diabetes mellitus; LVEF, left ventricular ejection fraction;MPR, myocardial perfusion
reserve; sMBF, stress myocardial blood flow
§Bootstrap based on 1000 samples
* P\ .05
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function, the present study showed a relative greater
influence of stress myocardial blood flow compared to
the myocardial perfusion reserve on systolic function.
LIMITATIONS
Our results are limited by the availability of alterna-
tive parameters to evaluate the status of the diabetic
patients such as HbA1c or time from diagnosis. Also, it
would have been of benefit to consider a complementary
technique for the evaluation of ventricular function.
Nevertheless, the technique described constitutes a valid
one for the evaluation of systolic function and the
reference standard for perfusion assessment in absolute
terms. Another limitation would be that we did not
include data related to invasive angiographic evaluation
since only a small proportion of the sample underwent the
procedure, even so, univariate correlations between
quantitative perfusion and systolic function were similar
in these patients and ischemic burden may have over-
shadowed other potential effects. Additionally, regional
flow was not considered separately and although of
interest, we aimed to account for the global perfusion
status and its influence on the ventricular function.
Therefore, the influence of specific regional measures
cannot be evaluated from this study alone. Finally, our
population showed a discrete prevalence of DM2 patients,
which might not concur with DM2 prevalence in patients
referred to cardiac PET imaging; nevertheless, it portraits
the prevalence in the general population as well as in
previous published reports.13,14,18
CONCLUSION
Diabetes mellitus significantly influences PET-mea-
sured systolic function in patients without a previous
myocardial infarction, independently from myocardial
perfusion parameters. Our study supports the importance
of diabetes mellitus as an independent risk factor for
deteriorating systolic function.
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